Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial
Authors
Keywords
Drug metabolism, Critical care and emergency medicine, Drug-drug interactions, Pharmacogenetics, Drug interactions, Drugs, Enzyme metabolism, Drug therapy
Journal
PLoS One
Volume 12, Issue 2, Pages e0170905
Publisher
Public Library of Science (PLoS)
Online
2017-02-03
DOI
10.1371/journal.pone.0170905
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytochrome P-450 gene and drug interaction analysis in patients referred for pharmacogenetic testing
- (2015) B. T. Hocum et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing
- (2015) KA Birdwell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
- (2015) JK Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol
- (2015) Patteet Lisbeth et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions
- (2015) O Alagoz et al. PHARMACOGENOMICS JOURNAL
- The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy
- (2015) D. Brixner et al. JOURNAL OF MEDICAL ECONOMICS
- How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping
- (2014) Paul Verbeurgt et al. PHARMACOGENOMICS
- The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies
- (2014) Brennan C Kahan et al. Trials
- Emergency Department Visits by Adults for Psychiatric Medication Adverse Events
- (2014) Lee M. Hampton et al. JAMA Psychiatry
- Adjusting for multiple prognostic factors in the analysis of randomised trials
- (2013) Brennan C Kahan et al. BMC Medical Research Methodology
- A Review of Pharmacogenetics of Adverse Drug Reactions in Elderly People
- (2013) Maurizio Cardelli et al. DRUG SAFETY
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- Adverse Drug Reactions in Elderly Hospitalized Patients: A 12-Year Population-Based Retrospective Cohort Study
- (2012) Khokan C Sikdar et al. ANNALS OF PHARMACOTHERAPY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Emergency Hospitalizations for Adverse Drug Events in Older Americans
- (2011) Daniel S. Budnitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Triple Aim: Care, Health, And Cost
- (2008) Donald M. Berwick et al. HEALTH AFFAIRS
- Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States
- (2008) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search